Highlights Sodium-glucose cotransporter-2 inhibitors (SGLT2-i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) provide modest but clinically meaningful blood pressure (BP) lowering effects in people with hypertension and cardiometabolic comorbidities
Bruzzese L, Rostain J-C, Ne L, Condo J, Mottola G, Adjriou N, Mercier L, Berge-Lefranc J-L, Fromonot J, Kipson N, Lucciano M, Durand-Gorde J-M, Jammes Y, Guieu R, Ruf J, Fenouillet E
And with that drug comes many dietary changes that need to be addressed
Key Advantages: Direct mitochondrial action, no GH axis involvement, supports cellular resilience
The best glutathione and Vitamin C brightening serum in Pakistan for glass skin, dark spots, and a complexion that glows from within